Medolac is a Public Benefit life sciences company committed to ending the global shortage of human donor milk. The first commercially sterile human donor milk was developed by Medolac and is currently being used by hospitals across the United States. The company specializes in innovative, human dono…
Medolac is a Public Benefit life sciences company committed to ending the global shortage of human donor milk. The first commercially sterile human donor milk was developed by Medolac and is currently being used by hospitals across the United States. The company specializes in innovative, human donor milk products for clinical use, applying proprietary bio pharmaceutical processing methods that preserve many of the immune components in human milk. As a public benefit company dedicated to social impact, Medolac Laboratories is a Delaware registered corporation headquartered at Lake Oswego, Oregon in the Pacific Northwest of the United States.
Medolac's status as a Public Benefit Corporation was approved unanimously by its shareholders and ushers in a new era of social impact advocacy and investment in human milk banking. This new form of corporation allows Medolac Laboratories and its board to consider the balanced interests of a broad set of stakeholders affected by its business.
Team (1)
Sectors Medolac Laboratories serves:
Life Sciences
Join Axial's Private M&A Platform
Medolac Laboratories connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
